Literature DB >> 12869840

Coronary heart disease in HIV-infected individuals.

Judith S Currier1, Anne Taylor, Felicity Boyd, Christopher M Dezii, Hugh Kawabata, Beth Burtcel, Jen-Fue Maa, Sally Hodder.   

Abstract

It is currently unknown whether there is an increased risk of coronary heart disease (CHD) in patients with HIV infection. In addition, the contribution of antiretroviral therapy (ART) to CHD risk has not been quantified. We reviewed administrative claims data for HIV-infected and -uninfected individuals from the California Medicaid population and compared the incidence of and relative risk (RR) for CHD using log-linear regression analyses between groups. The association between exposure to ART and CHD incidence was also assessed. Of 3,083,209 individuals analyzed, 28,513 were HIV-infected. The incidence of CHD among young men (up to age 34) and women (up to age 44) with HIV infection was significantly higher than that among non-HIV-infected individuals. The covariate-adjusted RR for the development of CHD in individuals receiving ART compared with those not receiving ART was 2.06 (P < 0.001) in HIV-infected individuals aged 18-33 years. There were no statistically significant associations between ART exposure and CHD in other age groups. CHD incidence appears accelerated among young HIV-infected individuals. Strategies to reduce CHD risk should be incorporated into HIV primary care.

Entities:  

Mesh:

Year:  2003        PMID: 12869840     DOI: 10.1097/00126334-200308010-00012

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  192 in total

Review 1.  Dyslipidemia and its Treatment in HIV Infection.

Authors:  Carl Grunfeld
Journal:  Top HIV Med       Date:  2010 Aug-Sep

2.  Ultrasonography in lesions of the carotid vessels in HIV positive patients.

Authors:  M Cristofaro; S Cicalini; E Busi Rizzi; V Schininà; N Petrosillo; C Bibbolino
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

3.  Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.

Authors:  Rebeccah A McKibben; Joseph B Margolick; Steven Grinspoon; Xiuhong Li; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Richard T George; Lisa P Jacobson; Matthew Budoff; Russell P Tracy; Todd T Brown; Wendy S Post
Journal:  J Infect Dis       Date:  2014-10-30       Impact factor: 5.226

4.  Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease.

Authors:  Adeel A Butt; Chung-Chou Chang; Lewis Kuller; Matthew Bidwell Goetz; David Leaf; David Rimland; Cynthia L Gibert; Krisann K Oursler; Maria C Rodriguez-Barradas; Joseph Lim; Lewis E Kazis; Stephen Gottlieb; Amy C Justice; Matthew S Freiberg
Journal:  Arch Intern Med       Date:  2011-04-25

5.  The new epidemic of non-communicable disease in people living with the human immunodeficiency virus.

Authors:  R Dawson; W N Rom; K Dheda; E D Bateman
Journal:  Public Health Action       Date:  2013-03-21

Review 6.  Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy.

Authors:  Phyllis C Tien
Journal:  Curr Atheroscler Rep       Date:  2015-12       Impact factor: 5.113

7.  The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men.

Authors:  Matthew S Freiberg; Kathleen A McGinnis; Kevin Kraemer; Jeffrey H Samet; Joseph Conigliaro; R Curtis Ellison; Kendall Bryant; Lewis H Kuller; Amy C Justice
Journal:  J Acquir Immune Defic Syndr       Date:  2010-02       Impact factor: 3.731

8.  Association of T Cell and Macrophage Activation with Arterial Vascular Health in HIV.

Authors:  Heather N Grome; Louise Barnett; Cindy C Hagar; David G Harrison; Spyros A Kalams; John R Koethe
Journal:  AIDS Res Hum Retroviruses       Date:  2016-09-14       Impact factor: 2.205

9.  Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).

Authors:  Elizabeth M Kiefer; Qiuhu Shi; Donald R Hoover; Robert Kaplan; Russell Tracy; Michael Augenbraun; Chenglong Liu; Marek Nowicki; Phyllis C Tien; Mardge Cohen; Elizabeth T Golub; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

10.  Coronary Heart Disease (CHD) Risk Factors and Metabolic Syndrome in HIV-Positive Drug Users in Miami.

Authors:  Marianna K Baum; Carlin Rafie; Shenghan Lai; Lihua Xue; Sabrina Sales; J Bryan Page; Ronald Berkman; Linden Karas; Adriana Campa
Journal:  Am J Infect Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.